← Back

Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Price · split & dividend adjusted
News & notes moving YPSN.SW
YPSN.SW

Medication Adherence Market to Reach $15.35 Billion by 2035

The global medication adherence market is projected to grow from USD 6.08 billion in 2026 to USD 15.35 billion by 2035, at a compound annual growth rate of 10.92%, according to a new report from ResearchAndMarkets.com. The market's expansion is driven by rising chronic disease prevalence, an aging population, and adoption of digital health technologies. Software-centric solutions currently account for about 65% of the market, while hardware-centric solutions are expected to see faster growth. North America remains the largest regional market, with Asia-Pacific growing fastest. Key players include Medtronic, Roche, Insulet, Ypsomed, and 13 others.
GlobeNewswire·22hRead more ▾